Related references
Note: Only part of the references are listed.An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
Paul J. Schmidt et al.
BLOOD (2013)
Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Emilio Ramos et al.
BLOOD (2012)
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Antonella Nai et al.
BLOOD (2012)
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
Karin E. Finberg et al.
BLOOD (2011)
Two to Tango: Regulation of Mammalian Iron Metabolism
Matthias W. Hentze et al.
CELL (2010)
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Sara Gardenghi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Transferrin therapy ameliorates disease in β-thalassemic mice
Huihui Li et al.
NATURE MEDICINE (2010)
The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
Laura Silvestri et al.
CELL METABOLISM (2008)
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Karin E. Finberg et al.
NATURE GENETICS (2008)
The serine protease TMPRSS6 is required to sense iron deficiency
Xin Du et al.
SCIENCE (2008)
Share Paper
